Skip to main content
ISSCR 2025 Annual Meeting Main banner

Dhruv Sareen, PhD

Cedars-Sinai Medical Center

Dhruv Sareen received his Ph.D. from the UW-Madison, where he discovered pathways to eliminate cancer cells using the natural red wine derivative, resveratrol, and participated in its pre-clinical drug-development. Dr. Sareen is the founding director of the iPSC Core at the Cedars-Sinai and his laboratory is developing personalized stem cell disease models and therapeutics for patients with neurodegenerative and metabolic diseases. He now directs the new Cedars-Sinai Biomanufacturing Center (CBC) where he will lead the clinical autologous and allogeneic programs for development of innovative products including stem cell (iPSC and adult)-based cell therapies produced under current good manufacturing practices (cGMP). There he will also support commercial contract cGMP cell manufacturing and provide oversight of research operations, quality assurance, and implementation of advanced cell-processing procedures .

Presentation(s):